FOCP, EHS partner to drive national cancer detection efforts
The agreement, signed by Dr Shamsa Majid Lootah, Director of the Public Health Department at EHS, and Aisha Al Mulla, Director of FOCP, underscores FOCP's ongoing commitment to working collaboratively with national healthcare institutions to benefit the wider community. It sets out a framework for expanding early detection programmes and strengthening both financial and emotional assistance for patients.
EHS has long been a strategic partner of FOCP, with both organisations having previously joined forces on cancer awareness initiatives. The renewed partnership provides a platform to broaden the scope of collaboration and align efforts in support of the UAE's national strategy to curb cancer prevalence and lessen its impact on patients and their families.
A strategic step towards shared goals
Commenting on the partnership, Dr. Essam Al Zarouni, Acting Executive Director of the Medical Services Sector at EHS, affirmed that the MoU represents an advanced integration model among national sectors pursuing the country's healthcare goals. This collaboration aligns with the National Strategy for Wellbeing 2031 objectives and the UAE Centennial 2071.
For her part, Dr. Shamsa Lootah highlighted that EHS is committed to expanding strategic partnerships with key community stakeholders to support its focus on disease prevention and early detection, particularly for cancer. Through ongoing awareness programmes and initiatives, EHS aims to raise public awareness, encourage healthy lifestyles and improve early diagnosis and treatment, in line with its commitment to comprehensive healthcare.
Aisha Al Mulla, Director of FOCP, said: 'The new partnership with EHS represents a significant step forward in our shared mission to raise community awareness of cancer and strengthen patient support systems. It builds on a longstanding collaboration between us. It reflects our joint conviction that coordinated efforts between the non-profit and healthcare sectors are vital to advancing early detection, improving prevention, and alleviating the challenges faced by patients and their families throughout their treatment journey.'
Patient support and assessment
As part of the agreement, FOCP's Patient Affairs Department will assess each cancer case to determine eligibility for financial assistance, in line with the organisation's established policies and procedures. In parallel, it will provide moral support, acknowledging its essential role in enhancing treatment outcomes and overall patient well-being.
Awareness campaigns and joint programmes
FOCP and EHS will collaborate on early cancer detection initiatives through public awareness campaigns, joint research projects, and specialised workshops and conferences. These efforts are designed to expand access to cancer-related services within the community, supporting prevention, early detection, and effective treatment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gulf Today
22-05-2025
- Gulf Today
FOCP, EHS to drive cancer detection efforts
Friends of Cancer Patients (FOCP) and Emirates Health Services (EHS) have signed a new partnership at Sofitel Dubai The Obelisk, to enhance cooperation in cancer prevention, early detection, and to provide both moral and financial support to patients across the UAE. The agreement, signed by Dr Shamsa Majid Lootah, Director of the Public Health Department at EHS, and Aisha Al Mulla, Director of FOCP, underscores FOCP's ongoing commitment to working collaboratively with national healthcare institutions to benefit the wider community. It sets out a framework for expanding early detection programmes and strengthening both financial and emotional assistance for patients. EHS has long been a strategic partner of FOCP, with both organisations having previously joined forces on cancer awareness initiatives. The renewed partnership provides a platform to broaden the scope of collaboration and align efforts in support of the UAE's national strategy to curb cancer prevalence and lessen its impact on patients and their families. Commenting on the partnership, Dr. Essam Al Zarouni, Acting Executive Director of the Medical Services Sector at EHS, affirmed that the MoU represents an advanced integration model among national sectors pursuing the country's healthcare goals. This collaboration aligns with the National Strategy for Wellbeing 2031 objectives and the UAE Centennial 2071. For her part, Dr Shamsa Lootah highlighted that EHS is committed to expanding strategic partnerships with key community stakeholders to support its focus on disease prevention and early detection, particularly for cancer. Through ongoing awareness programmes and initiatives, EHS aims to raise public awareness, encourage healthy lifestyles and improve early diagnosis and treatment, in line with its commitment to comprehensive healthcare. Aisha Al Mulla, Director of FOCP, said: 'The new partnership with EHS represents a significant step forward in our shared mission to raise community awareness of cancer and strengthen patient support systems. It builds on a longstanding collaboration between us.
Sharjah 24
21-05-2025
- Sharjah 24
FOCP, EHS partner to drive national cancer detection efforts
The agreement, signed by Dr Shamsa Majid Lootah, Director of the Public Health Department at EHS, and Aisha Al Mulla, Director of FOCP, underscores FOCP's ongoing commitment to working collaboratively with national healthcare institutions to benefit the wider community. It sets out a framework for expanding early detection programmes and strengthening both financial and emotional assistance for patients. EHS has long been a strategic partner of FOCP, with both organisations having previously joined forces on cancer awareness initiatives. The renewed partnership provides a platform to broaden the scope of collaboration and align efforts in support of the UAE's national strategy to curb cancer prevalence and lessen its impact on patients and their families. A strategic step towards shared goals Commenting on the partnership, Dr. Essam Al Zarouni, Acting Executive Director of the Medical Services Sector at EHS, affirmed that the MoU represents an advanced integration model among national sectors pursuing the country's healthcare goals. This collaboration aligns with the National Strategy for Wellbeing 2031 objectives and the UAE Centennial 2071. For her part, Dr. Shamsa Lootah highlighted that EHS is committed to expanding strategic partnerships with key community stakeholders to support its focus on disease prevention and early detection, particularly for cancer. Through ongoing awareness programmes and initiatives, EHS aims to raise public awareness, encourage healthy lifestyles and improve early diagnosis and treatment, in line with its commitment to comprehensive healthcare. Aisha Al Mulla, Director of FOCP, said: 'The new partnership with EHS represents a significant step forward in our shared mission to raise community awareness of cancer and strengthen patient support systems. It builds on a longstanding collaboration between us. It reflects our joint conviction that coordinated efforts between the non-profit and healthcare sectors are vital to advancing early detection, improving prevention, and alleviating the challenges faced by patients and their families throughout their treatment journey.' Patient support and assessment As part of the agreement, FOCP's Patient Affairs Department will assess each cancer case to determine eligibility for financial assistance, in line with the organisation's established policies and procedures. In parallel, it will provide moral support, acknowledging its essential role in enhancing treatment outcomes and overall patient well-being. Awareness campaigns and joint programmes FOCP and EHS will collaborate on early cancer detection initiatives through public awareness campaigns, joint research projects, and specialised workshops and conferences. These efforts are designed to expand access to cancer-related services within the community, supporting prevention, early detection, and effective treatment.
Arabian Post
20-05-2025
- Arabian Post
Mubadala Bio Emerges as Pillar of UAE's Healthcare Vision
Mubadala Investment Company has unveiled Mubadala Bio, a new life sciences entity designed to bolster the United Arab Emirates' pharmaceutical manufacturing capabilities and enhance healthcare resilience. The initiative aligns with the country's Centennial 2071 vision, aiming to position Abu Dhabi as a regional hub for biopharmaceutical innovation. Mubadala Bio's infrastructure encompasses ten facilities across Asia, Africa, and Europe, with six situated within the UAE. Collectively, these sites span 110,000 square metres and possess an annual production capacity exceeding 2.5 billion tablets and capsules, along with 120 million intravenous and injectable units. The company's extensive portfolio includes over 10,000 medical products, serving more than 100 countries worldwide. The company's focus extends across the entire continuum of care, from prevention and diagnostics to treatment and supportive therapies. This comprehensive approach aims to address pressing global health challenges and improve patient outcomes. Dr. Bakheet Al Katheeri, CEO of Mubadala's UAE Investments Platform, stated that the launch of Mubadala Bio represents a transformative step toward strengthening national drug security and fostering innovation in life sciences. He emphasized that this positions Mubadala at the forefront of the industry, enabling long-term economic growth and the development of a resilient life sciences ecosystem. Ismail Ali Abdulla, Executive Director of UAE Clusters at Mubadala, highlighted the company's commitment to supporting the UAE's ambition to become a global leader in the life sciences industry. By focusing on local manufacturing and enhancing distribution and logistics capabilities, Mubadala Bio aims to build a self-sustaining sector prepared for future challenges. Mubadala Bio plans to establish strategic partnerships with global life sciences firms and academic institutions to accelerate biopharmaceutical innovation and nurture world-class talent within the UAE. These collaborations are intended to drive advancements in healthcare and support the country's transition to a knowledge-based economy. See also UAE Airlines Resume Flights to Pakistan After Airspace Reopening The company's launch will be formally introduced at the upcoming Make it in the Emirates 2025 event, showcasing the UAE's success in building a competitive life sciences industry. This event serves as a national industrial showcase, reinforcing the country's position as a hub for innovation and local manufacturing. Mubadala Bio is designated as one of Mubadala's 'National Champions,' entities established to support strategic sectors aligned with the UAE's long-term development goals. Through its initiatives, the company aims to accelerate the UAE's economic diversification, particularly in healthcare and biotechnology.
